retatrutide gip glp-1 glucagon receptor agonist 40mg Triple G Agonists – Retatrutide.

6 Similarly, as GLP-1RAs significantly reduced the risk of MACE, mortality from CV causes, when compared with placebo, ADA has suggested that these medications should be used in patients with underlying cardiovascular disease

While both peptides share similarities in administration, subtle differences exist

Many Reddit users report GLP-1 side effects such as constipation, diarrhea, fatigue, low appetite, and nausea

& Rosenkilde, M

Novel GLP-1 mimetics in diabetes: lixisenatide and albiglutide

Data analysed by paired two-tailed Students t-test ( j - m ), unpaired two-tailed Students t-test ( p and r ), one-way ANOVA, multiple comparison, Bonferroni post hoc test ( h ) and two-way repeated measures ANOVA to assess main effects of treatment ( c , d and s - v )